BRIEF-Galapagos, MorphoSys Announce Initiation Of Gecko Phase 2 Study
April 24, 2019 at 03:21 AM EDT
* GECKO IS A PHASE 2 STUDY TESTING A SUBCUTANEOUS FORMULATION OF MOR106 IN COMBINATION WITH TOPICAL CORTICOSTEROIDS IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
